LYONDELLBASELL INDU-CL A (LYB) Stock Fundamental Analysis

NYSE:LYB • NL0009434992

57.61 USD
-0.17 (-0.29%)
At close: Feb 13, 2026
57.61 USD
0 (0%)
After Hours: 2/13/2026, 8:22:25 PM
Fundamental Rating

3

Overall LYB gets a fundamental rating of 3 out of 10. We evaluated LYB against 83 industry peers in the Chemicals industry. LYB has a bad profitability rating. Also its financial health evaluation is rather negative. LYB is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • LYB had positive earnings in the past year.
  • LYB had a positive operating cash flow in the past year.
  • LYB had positive earnings in 4 of the past 5 years.
  • Of the past 5 years LYB 4 years had a positive operating cash flow.
LYB Yearly Net Income VS EBIT VS OCF VS FCFLYB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

1.2 Ratios

  • LYB's Return On Assets of -3.59% is on the low side compared to the rest of the industry. LYB is outperformed by 63.86% of its industry peers.
  • LYB has a Return On Equity of -11.44%. This is in the lower half of the industry: LYB underperforms 66.27% of its industry peers.
  • LYB has a Return On Invested Capital of 3.64%. This is comparable to the rest of the industry: LYB outperforms 53.01% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for LYB is above the industry average of 6.07%.
  • The last Return On Invested Capital (3.64%) for LYB is well below the 3 year average (10.69%), which needs to be investigated, but indicates that LYB had better years and this may not be a problem.
Industry RankSector Rank
ROA -3.59%
ROE -11.44%
ROIC 3.64%
ROA(3y)6.72%
ROA(5y)7.89%
ROE(3y)19.31%
ROE(5y)24.61%
ROIC(3y)10.69%
ROIC(5y)11.69%
LYB Yearly ROA, ROE, ROICLYB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

1.3 Margins

  • LYB's Profit Margin has declined in the last couple of years.
  • The Operating Margin of LYB (3.65%) is worse than 61.45% of its industry peers.
  • LYB's Operating Margin has declined in the last couple of years.
  • LYB has a Gross Margin of 9.19%. This is amonst the worse of the industry: LYB underperforms 83.13% of its industry peers.
  • In the last couple of years the Gross Margin of LYB has declined.
Industry RankSector Rank
OM 3.65%
PM (TTM) N/A
GM 9.19%
OM growth 3Y-24.61%
OM growth 5Y-10.5%
PM growth 3Y-34.85%
PM growth 5Y-19.21%
GM growth 3Y-15.85%
GM growth 5Y-6.35%
LYB Yearly Profit, Operating, Gross MarginsLYB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

2

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so LYB is still creating some value.
  • There is no outstanding debt for LYB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
LYB Yearly Shares OutstandingLYB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
LYB Yearly Total Debt VS Total AssetsLYB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

  • An Altman-Z score of 2.00 indicates that LYB is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.00, LYB is in line with its industry, outperforming 53.01% of the companies in the same industry.
  • LYB has a debt to FCF ratio of 16.07. This is a negative value and a sign of low solvency as LYB would need 16.07 years to pay back of all of its debts.
  • LYB has a Debt to FCF ratio (16.07) which is comparable to the rest of the industry.
  • A Debt/Equity ratio of 1.02 is on the high side and indicates that LYB has dependencies on debt financing.
  • The Debt to Equity ratio of LYB (1.02) is worse than 67.47% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF 16.07
Altman-Z 2
ROIC/WACC0.46
WACC7.9%
LYB Yearly LT Debt VS Equity VS FCFLYB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

  • LYB has a Current Ratio of 1.57. This is a normal value and indicates that LYB is financially healthy and should not expect problems in meeting its short term obligations.
  • LYB has a Current ratio of 1.57. This is in the lower half of the industry: LYB underperforms 66.27% of its industry peers.
  • LYB has a Quick Ratio of 1.57. This is a bad value and indicates that LYB is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of LYB (0.93) is worse than 66.27% of its industry peers.
Industry RankSector Rank
Current Ratio 1.57
Quick Ratio 0.93
LYB Yearly Current Assets VS Current LiabilitesLYB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2

3. Growth

3.1 Past

  • LYB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -73.44%.
  • Measured over the past years, LYB shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -21.44% on average per year.
EPS 1Y (TTM)-73.44%
EPS 3Y-48.49%
EPS 5Y-21.44%
EPS Q2Q%-134.67%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-25.33%

3.2 Future

  • The Earnings Per Share is expected to grow by 48.11% on average over the next years. This is a very strong growth
  • The Revenue is expected to decrease by -0.68% on average over the next years.
EPS Next Y58.88%
EPS Next 2Y51.34%
EPS Next 3Y45.54%
EPS Next 5Y48.11%
Revenue Next Year-1.4%
Revenue Next 2Y-0.37%
Revenue Next 3Y0.93%
Revenue Next 5Y-0.68%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
LYB Yearly Revenue VS EstimatesLYB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B 40B 50B
LYB Yearly EPS VS EstimatesLYB Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5 10 15

4

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 33.89, the valuation of LYB can be described as expensive.
  • LYB's Price/Earnings ratio is in line with the industry average.
  • LYB's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.19.
  • A Price/Forward Earnings ratio of 21.33 indicates a rather expensive valuation of LYB.
  • LYB's Price/Forward Earnings is on the same level as the industry average.
  • LYB is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 28.06, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 33.89
Fwd PE 21.33
LYB Price Earnings VS Forward Price EarningsLYB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • LYB's Enterprise Value to EBITDA is on the same level as the industry average.
  • Based on the Price/Free Cash Flow ratio, LYB is valued a bit cheaper than the industry average as 67.47% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 25.14
EV/EBITDA 11.04
LYB Per share dataLYB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • LYB's earnings are expected to grow with 45.54% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.58
PEG (5Y)N/A
EPS Next 2Y51.34%
EPS Next 3Y45.54%

6

5. Dividend

5.1 Amount

  • LYB has a Yearly Dividend Yield of 9.48%, which is a nice return.
  • Compared to an average industry Dividend Yield of 2.15, LYB pays a better dividend. On top of this LYB pays more dividend than 93.98% of the companies listed in the same industry.
  • LYB's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 9.48%

5.2 History

  • The dividend of LYB has a limited annual growth rate of 5.17%.
  • LYB has paid a dividend for at least 10 years, which is a reliable track record.
  • The dividend of LYB decreased recently.
Dividend Growth(5Y)5.17%
Div Incr Years1
Div Non Decr Years1
LYB Yearly Dividends per shareLYB Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8

5.3 Sustainability

  • LYB has negative earnings and hence a negative payout ratio. The dividend may be in danger.
  • The dividend of LYB is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-144.93%
EPS Next 2Y51.34%
EPS Next 3Y45.54%
LYB Yearly Income VS Free CF VS DividendLYB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

LYONDELLBASELL INDU-CL A

NYSE:LYB (2/13/2026, 8:22:25 PM)

After market: 57.61 0 (0%)

57.61

-0.17 (-0.29%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)01-30
Earnings (Next)04-23
Inst Owners71.84%
Inst Owner Change-0.31%
Ins Owners0.18%
Ins Owner Change0.01%
Market Cap18.55B
Revenue(TTM)N/A
Net Income(TTM)-1.21B
Analysts52.14
Price Target52.08 (-9.6%)
Short Float %8.43%
Short Ratio3.47
Dividend
Industry RankSector Rank
Dividend Yield 9.48%
Yearly Dividend5.31
Dividend Growth(5Y)5.17%
DP-144.93%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.36%
Min EPS beat(2)-23.45%
Max EPS beat(2)24.17%
EPS beat(4)2
Avg EPS beat(4)-4.8%
Min EPS beat(4)-23.45%
Max EPS beat(4)24.17%
EPS beat(8)4
Avg EPS beat(8)-1.26%
EPS beat(12)8
Avg EPS beat(12)5.26%
EPS beat(16)10
Avg EPS beat(16)2.78%
Revenue beat(2)2
Avg Revenue beat(2)2.02%
Min Revenue beat(2)0.76%
Max Revenue beat(2)3.27%
Revenue beat(4)4
Avg Revenue beat(4)1.93%
Min Revenue beat(4)0.76%
Max Revenue beat(4)3.27%
Revenue beat(8)6
Avg Revenue beat(8)0.64%
Revenue beat(12)7
Avg Revenue beat(12)-0.64%
Revenue beat(16)10
Avg Revenue beat(16)0.42%
PT rev (1m)0.32%
PT rev (3m)-11.29%
EPS NQ rev (1m)-16.2%
EPS NQ rev (3m)-78.71%
EPS NY rev (1m)-5.49%
EPS NY rev (3m)-12.2%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.38%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.19%
Valuation
Industry RankSector Rank
PE 33.89
Fwd PE 21.33
P/S 0.57
P/FCF 25.14
P/OCF 6.95
P/B 1.75
P/tB 1.97
EV/EBITDA 11.04
EPS(TTM)1.7
EY2.95%
EPS(NY)2.7
Fwd EY4.69%
FCF(TTM)2.29
FCFY3.98%
OCF(TTM)8.29
OCFY14.39%
SpS101.11
BVpS32.92
TBVpS29.31
PEG (NY)0.58
PEG (5Y)N/A
Graham Number35.48
Profitability
Industry RankSector Rank
ROA -3.59%
ROE -11.44%
ROCE 4.41%
ROIC 3.64%
ROICexc 3.89%
ROICexgc 4.08%
OM 3.65%
PM (TTM) N/A
GM 9.19%
FCFM 2.27%
ROA(3y)6.72%
ROA(5y)7.89%
ROE(3y)19.31%
ROE(5y)24.61%
ROIC(3y)10.69%
ROIC(5y)11.69%
ROICexc(3y)11.83%
ROICexc(5y)12.68%
ROICexgc(3y)12.95%
ROICexgc(5y)13.92%
ROCE(3y)12.98%
ROCE(5y)14.24%
ROICexgc growth 3Y-25.81%
ROICexgc growth 5Y-9.22%
ROICexc growth 3Y-25.6%
ROICexc growth 5Y-8.64%
OM growth 3Y-24.61%
OM growth 5Y-10.5%
PM growth 3Y-34.85%
PM growth 5Y-19.21%
GM growth 3Y-15.85%
GM growth 5Y-6.35%
F-Score3
Asset Turnover0.96
Health
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF 16.07
Debt/EBITDA 4.18
Cap/Depr 138.59%
Cap/Sales 5.93%
Interest Coverage 250
Cash Conversion 103.45%
Profit Quality N/A
Current Ratio 1.57
Quick Ratio 0.93
Altman-Z 2
F-Score3
WACC7.9%
ROIC/WACC0.46
Cap/Depr(3y)123.27%
Cap/Depr(5y)130.2%
Cap/Sales(3y)4.01%
Cap/Sales(5y)4.66%
Profit Quality(3y)139.02%
Profit Quality(5y)124.38%
High Growth Momentum
Growth
EPS 1Y (TTM)-73.44%
EPS 3Y-48.49%
EPS 5Y-21.44%
EPS Q2Q%-134.67%
EPS Next Y58.88%
EPS Next 2Y51.34%
EPS Next 3Y45.54%
EPS Next 5Y48.11%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-25.33%
Revenue Next Year-1.4%
Revenue Next 2Y-0.37%
Revenue Next 3Y0.93%
Revenue Next 5Y-0.68%
EBIT growth 1Y-60.92%
EBIT growth 3Y-27.96%
EBIT growth 5Y-7.79%
EBIT Next Year-11.44%
EBIT Next 3Y5.64%
EBIT Next 5Y10.29%
FCF growth 1Y-79.05%
FCF growth 3Y-29.85%
FCF growth 5Y-2.67%
OCF growth 1Y-47.04%
OCF growth 3Y-20.83%
OCF growth 5Y-5.1%

LYONDELLBASELL INDU-CL A / LYB FAQ

Can you provide the ChartMill fundamental rating for LYONDELLBASELL INDU-CL A?

ChartMill assigns a fundamental rating of 3 / 10 to LYB.


What is the valuation status of LYONDELLBASELL INDU-CL A (LYB) stock?

ChartMill assigns a valuation rating of 4 / 10 to LYONDELLBASELL INDU-CL A (LYB). This can be considered as Fairly Valued.


How profitable is LYONDELLBASELL INDU-CL A (LYB) stock?

LYONDELLBASELL INDU-CL A (LYB) has a profitability rating of 3 / 10.


How financially healthy is LYONDELLBASELL INDU-CL A?

The financial health rating of LYONDELLBASELL INDU-CL A (LYB) is 2 / 10.


What is the earnings growth outlook for LYONDELLBASELL INDU-CL A?

The Earnings per Share (EPS) of LYONDELLBASELL INDU-CL A (LYB) is expected to grow by 58.88% in the next year.